Optimizing Strategic Dose Selection in First-in-Human Trials Using MIDD: Enhancing Patient Safety & Accelerating Drug Development
Time: 9:00 am
day: Day 1
Details:
- How model-based predictions can guide safer, more effective dose selection
- Understand the key challenges that arise in FIH trials and how modelling can mitigate them
- Hear examples of FIH oncology trials accelerated through smarter starting dose strategies and how these have saved costs
